104 related articles for article (PubMed ID: 38735433)
1. Use of Bladder Epicheck® in the follow-up of high-risk non-muscle-invasive Bladder cancer: A systematic literature review.
Caño Velasco J; Artero Fullana S; Polanco Pujol L; Lafuente Puentedura A; Subiela JD; Aragón Chamizo J; Moralejo Gárate M; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2024 May; ():. PubMed ID: 38735433
[TBL] [Abstract][Full Text] [Related]
2. Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review.
Wolfs JRE; Hermans TJN; Koldewijn EL; van de Kerkhof D
Urol Oncol; 2021 Mar; 39(3):161-170. PubMed ID: 33376063
[TBL] [Abstract][Full Text] [Related]
3. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
Trenti E; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Pycha A; Kafka M; Degener S; Danuser H; Roth S; Pycha A
Cancer Cytopathol; 2019 Jul; 127(7):465-469. PubMed ID: 31154670
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor.
Palermo M; D'Elia C; Trenti E; Comploj E; Mian C; Schwienbacher C; Heidegger I; Clauser S; Pycha A; Vjaters E
Minerva Urol Nephrol; 2024 Apr; 76(2):195-202. PubMed ID: 38498297
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis.
Laukhtina E; Shim SR; Mori K; D'Andrea D; Soria F; Rajwa P; Mostafaei H; Compérat E; Cimadamore A; Moschini M; Teoh JY; Enikeev D; Xylinas E; Lotan Y; Palou J; Gontero P; Babjuk M; Witjes JA; Kamat AM; Roupret M; Shariat SF; Pradere B;
Eur Urol Oncol; 2021 Dec; 4(6):927-942. PubMed ID: 34753702
[TBL] [Abstract][Full Text] [Related]
7. The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer.
Ragonese M; Gianfrancesco LD; Palermo G; Pierconti F; Martini M; Foti M; Bassi P; Racioppi M
Clin Genitourin Cancer; 2022 Aug; 20(4):e271-e275. PubMed ID: 35871875
[TBL] [Abstract][Full Text] [Related]
8. The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma.
Pierconti F; Martini M; Cenci T; Fiorentino V; Gianfrancesco LD; Ragonese M; Bientinesi R; Rossi E; Larocca LM; Racioppi M; Bassi PF
Urol Oncol; 2022 Mar; 40(3):108.e19-108.e25. PubMed ID: 34903453
[TBL] [Abstract][Full Text] [Related]
9. Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker.
Rouprêt M; Gontero P; McCracken SRC; Dudderidge T; Stockley J; Kennedy A; Rodriguez O; Sieverink C; Vanié F; Allasia M; Witjes JA; Colombel M; Longo F; Montanari E; Palou J; Sylvester RJ
Eur Urol Focus; 2022 Nov; 8(6):1643-1649. PubMed ID: 35300937
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
D'Andrea D; Soria F; Zehetmayer S; Gust KM; Korn S; Witjes JA; Shariat SF
BJU Int; 2019 Jun; 123(6):959-967. PubMed ID: 30653818
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial.
Azawi N; Vásquez JL; Dreyer T; Guldhammer CS; Saber Al-Juboori RM; Nielsen AM; Jensen JB
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190269
[TBL] [Abstract][Full Text] [Related]
12. Bladder EpiCheck urine test in the follow-up of NMIBC: a cost analysis.
Hekman MCH; Wijn SRW; Lotan Y; Govers TM; Witjes JA
World J Urol; 2023 Feb; 41(2):471-476. PubMed ID: 36534153
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of Xpert® BC Detection, Bladder Epicheck®, Urovysion® FISH and cytology in the detection of upper urinary tract urothelial carcinoma.
Pycha S; Trenti E; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; D'Elia C
World J Urol; 2023 May; 41(5):1323-1328. PubMed ID: 36929411
[TBL] [Abstract][Full Text] [Related]
14. Urine-Based Biomarker Test Uromonitor
Kravchuk AP; Wolff I; Gilfrich C; Wirtz RM; Soares P; Braun KP; Brookman-May SD; Kollitsch L; Hauner K; Burchardt M; Bründl J; Burger M; May M
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398144
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of the Bladder EpiCheck methylation test and photodynamic diagnosis-guided cystoscopy in the surveillance of high-risk non-muscle invasive bladder cancer: A single centre, prospective, blinded clinical trial.
Cochetti G; Rossi de Vermandois JA; Maulà V; Cari L; Cagnani R; Suvieri C; Balducci PM; Paladini A; Del Zingaro M; Nocentini G; Mearini E
Urol Oncol; 2022 Mar; 40(3):105.e11-105.e18. PubMed ID: 34911649
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of Xpert
D'Elia C; Folchini DM; Mian C; Hanspeter E; Schwienbacher C; Spedicato GA; Pycha S; Vjaters E; Degener S; Kafka M; Pycha A; Trenti E
Ther Adv Urol; 2021; 13():1756287221997183. PubMed ID: 33747133
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
Trenti E; Pycha S; Mian C; Schwienbacher C; Hanspeter E; Kafka M; Spedicato GA; Vjaters E; Degener S; Pycha A; D'Elia C
Cancer Cytopathol; 2020 May; 128(5):341-347. PubMed ID: 31977131
[TBL] [Abstract][Full Text] [Related]
18. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples.
Fiorentino V; Pizzimenti C; Franchina M; Rossi ED; Tralongo P; Carlino A; Larocca LM; Martini M; Fadda G; Pierconti F
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569864
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer.
D Elia C; Pycha A; Folchini DM; Mian C; Hanspeter E; Schwienbacher C; Vjaters E; Pycha A; Trenti E
J Clin Pathol; 2019 Feb; 72(2):140-144. PubMed ID: 30355587
[TBL] [Abstract][Full Text] [Related]
20. DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial.
Territo A; Gallioli A; Diana P; Boissier R; Fontana M; Gaya JM; Sanguedolce F; Calderón J; Piana A; Fontanet S; Algaba F; Palou J; Breda A
J Urol; 2022 Sep; 208(3):570-579. PubMed ID: 35549312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
